Evaluate Releases Annual World Preview Report Revealing Updated Market Forecasts for the Pharmaceutical IndustryThe 2026 report highlights top drivers of global pharmaceutical sales, M&A, and China’s continued impact on the industry
Evaluate, a Norstella company, announces acquisition of J+D ForecastingLondon, UK & Boston, MA, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry.
MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making
Managed Markets Insight & Technology (MMIT) and Evaluate, (a Welsh, Carson, Anderson & Stowe and Hg portfolio company)—which joined forces last month to become a $1.6 billion global pharma commercial intelligence provider—announced the acquisition of Panalgo, a premier healthcare data analytics company that serves many of the largest biopharmaceutical, medical device and contract research organizations around the globe.
Evaluate Acquires Bioscience Advisors, Adding the Most Comprehensive Database of Biopharma Deals to Its Commercial Intelligence Portfolio
Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is delighted to announce that it has completed the acquisition of Bioscience Advisors Inc. (Biosci), a California-based data company focused on biopharma alliances. The acquisition will significantly expand the richness and quantity of biopharma deal data available to Evaluate clients, furthering Evaluate’s mission to provide the most complete and dynamic valuations of pharmaceutical assets.
